Catherine Welsh

Associate Professor of Clinical

  • 741 Citations
19922017

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Catherine Welsh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    • 741 Citations
    • 15 Article
    • 3 Review article
    • 1 Comment/debate

    A Breast Cancer Review: Through the Eyes of the Doctor, Nurse, and Patient

    Klevos, G., Ezuddin, N. S., Vinyard, A., Ghaddar, T., Gort, T., Almuna, A., Abisch, A. & Welsh, C., Sep 1 2017, In : Journal of Radiology Nursing. 36, 3, p. 158-165 8 p.

    Research output: Contribution to journalReview article

  • 4 Scopus citations

    Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer

    Montero, A. J., Diaz-Montero, C. M., Deutsch, Y. E., Hurley, J., Koniaris, L. G., Rumboldt, T., Yasir, S., Jorda, M., Garret-Mayer, E., Avisar, E., Slingerland, J., Silva, O., Welsh, C., Schuhwerk, K., Seo, P., Pegram, M. D. & Glück, S., Feb 2012, In : Breast cancer research and treatment. 132, 1, p. 215-223 9 p.

    Research output: Contribution to journalArticle

  • 55 Scopus citations

    Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

    Lobo, C., Lopes, G., Baez, O., Castrellon, A., Ferrell, A., Higgins, C., Hurley, E., Hurley, J., Reis, I., Richman, S., Seo, P., Silva, O. E., Slingerland, J., Tukia, K., Welsh, C. & Gluck, S., Sep 1 2010, In : Breast cancer research and treatment. 123, 2, p. 427-435 9 p.

    Research output: Contribution to journalArticle

  • 57 Scopus citations

    Erratum: Timing of cyclin D1 expression within G1 phase is controlled by Rho (Nature Cell Biology (2001) 3 (950-957))

    Welsh, C. F., Roovers, K., Villanueva, J., Liu, Y., Schwartz, M. A. & Assoian, R. K., Dec 1 2009, In : Nature Cell Biology. 11, 12, 1 p.

    Research output: Contribution to journalComment/debate

    A phase II trial of split, low-dose docetaxel and low-dose capecitabine: A tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancer

    Silva, O., Lopes, G., Morgenzstern, D., Lobo, C., Doliny, P., Santos, E., Abdullah, S., Gautam, U., Reis, I., Welsh, C., Slingerland, J., Hurley, J. & Gluck, S., Apr 2008, In : Clinical breast cancer. 8, 2, p. 162-167 6 p.

    Research output: Contribution to journalArticle

  • 11 Scopus citations